The fastest-growing and largest of the 26 sized Medical Devices markets in North America, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Anesthesia Monitoring Devices | $1.3 Bn | $3.9 Bn | 11.5% | 76 |
| 2 | Aesthetic Lasers and Energy Devices | $810 Mn | $2.3 Bn | 11.1% | 70 |
| 3 | Insulin Patch Pumps | $445 Mn | $1.3 Bn | 11% | 8 |
| 4 | Dental Caries Detectors | $185 Mn | $516 Mn | 10.8% | 19 |
| 5 | Anesthesia & Respiratory Devices | $14.4 Bn | $32.4 Bn | 8.5% | 145 |
| 6 | Air Ambulance Life Support Solutions | $2.2 Bn | $4.9 Bn | 8.1% | 7 |
| 7 | Anti-Snoring Devices | $625 Mn | $1.3 Bn | 7.8% | 108 |
| 8 | Advanced Bipolar Direct Energy Devices | $1.6 Bn | $3.3 Bn | 7.7% | 242 |
| 9 | Acute Care Needleless Connectors | $245 Mn | $460 Mn | 6.5% | 1 |
| 10 | Disposable Surgical Devices | $4.5 Bn | $8.3 Bn | 6.3% | 5,848 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Diabetes Care Devices | $21.3 Bn | $34.4 Bn | 4.9% | 348 |
| 2 | Anesthesia & Respiratory Devices | $14.4 Bn | $32.4 Bn | 8.5% | 145 |
| 3 | Rehabilitation Equipments | $10 Bn | $16.5 Bn | 5.1% | 686 |
| 4 | Defibrillator | $8.9 Bn | $14.3 Bn | 4.9% | 138 |
| 5 | Insulin Delivery Devices | $7.9 Bn | $13.6 Bn | 5.5% | 158 |
| 6 | Angiography Devices | $6.2 Bn | $10.4 Bn | 5.3% | 475 |
| 7 | Dental Diagnostic and Surgical Equipments | $6 Bn | $10.8 Bn | 6.1% | 1,369 |
| 8 | Direct Energy Medical Devices | $5.5 Bn | $8.2 Bn | 4% | 482 |
| 9 | Disposable Surgical Devices | $4.5 Bn | $8.3 Bn | 6.3% | 5,848 |
| 10 | Audiology Devices | $3.9 Bn | $6.6 Bn | 5.4% | 135 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running, in US, Canada.
Anesthesia Monitoring Devices grows fastest, at 11.5% a year from 2023 to 2033, ahead of Aesthetic Lasers and Energy Devices (11.1%).
Diabetes Care Devices is the largest, worth about $21.3 Bn in 2023 and $34.4 Bn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.